INS and metabolic syndrome: This condition, characterized by a decreased ability of peripheral tissues to respond adequately to insulin, plays a crucial role in the onset of conditions such as metabolic syndrome [1], type 2 diabetes mellitus (T2DM) [2], and other related conditions, including hypertension [3], dyslipidemia [4], and cardiovascular disease (CVD) [5].